Amy Mcbride Wendell - Net Worth and Insider Trading

Amy Mcbride Wendell Net Worth

The estimated net worth of Amy Mcbride Wendell is at least $2 Million dollars as of 2024-11-08. Amy Mcbride Wendell is the Director of Axogen Inc and owns about 80,342 shares of Axogen Inc (AXGN) stock worth over $1 Million. Amy Mcbride Wendell is the Director of Hologic Inc and owns about 10,297 shares of Hologic Inc (HOLX) stock worth over $816,449. Amy Mcbride Wendell is also the Director of Ekso Bionics Holdings Inc and owns about 1,084 shares of Ekso Bionics Holdings Inc (EKSO) stock worth over $965. Details can be seen in Amy Mcbride Wendell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amy Mcbride Wendell has not made any transactions after 2023-09-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Amy Mcbride Wendell

To

Amy Mcbride Wendell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amy Mcbride Wendell owns 4 companies in total, including Axogen Inc (AXGN) , Baxter International Inc (BAX) , and Hologic Inc (HOLX) among others .

Click here to see the complete history of Amy Mcbride Wendell’s form 4 insider trades.

Insider Ownership Summary of Amy Mcbride Wendell

Ticker Comapny Transaction Date Type of Owner
AXGN Axogen Inc 2023-09-06 director
BAX Baxter International Inc 2022-05-03 director
HOLX Hologic Inc 2018-03-14 director
LIMIT LIMIT 2017-09-14 director

Amy Mcbride Wendell Latest Holdings Summary

Amy Mcbride Wendell currently owns a total of 3 stocks. Among these stocks, Amy Mcbride Wendell owns 80,342 shares of Axogen Inc (AXGN) as of September 6, 2023, with a value of $1 Million and a weighting of 56.6%. Amy Mcbride Wendell owns 10,297 shares of Hologic Inc (HOLX) as of March 14, 2018, with a value of $816,449 and a weighting of 43.35%. Amy Mcbride Wendell also owns 1,084 shares of Ekso Bionics Holdings Inc (EKSO) as of September 14, 2017, with a value of $965 and a weighting of 0.05%.

Latest Holdings of Amy Mcbride Wendell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AXGN Axogen Inc 2023-09-06 80,342 13.27 1,066,138
HOLX Hologic Inc 2018-03-14 10,297 79.29 816,449
EKSO Ekso Bionics Holdings Inc 2017-09-14 1,084 0.89 965

Holding Weightings of Amy Mcbride Wendell


Amy Mcbride Wendell Form 4 Trading Tracker

According to the SEC Form 4 filings, Amy Mcbride Wendell has made a total of 1 transactions in Axogen Inc (AXGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Axogen Inc is the acquisition of 10,000 shares on September 6, 2023, which cost Amy Mcbride Wendell around $62,200.

According to the SEC Form 4 filings, Amy Mcbride Wendell has made a total of 0 transactions in Hologic Inc (HOLX) over the past 5 years. The most-recent trade in Hologic Inc is the acquisition of 5,200 shares on March 14, 2018, which cost Amy Mcbride Wendell around $199,836.

According to the SEC Form 4 filings, Amy Mcbride Wendell has made a total of 0 transactions in Ekso Bionics Holdings Inc (EKSO) over the past 5 years. The most-recent trade in Ekso Bionics Holdings Inc is the acquisition of 1,084 shares on September 14, 2017, which cost Amy Mcbride Wendell around $20,005.

Insider Trading History of Amy Mcbride Wendell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Amy Mcbride Wendell Trading Performance

GuruFocus tracks the stock performance after each of Amy Mcbride Wendell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amy Mcbride Wendell is 13.55%. GuruFocus also compares Amy Mcbride Wendell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amy Mcbride Wendell within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Amy Mcbride Wendell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Amy Mcbride Wendell

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -8.45 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -8.59 LIMIT LIMIT LIMIT LIMIT LIMIT

Amy Mcbride Wendell Ownership Network

Ownership Network List of Amy Mcbride Wendell

No Data

Ownership Network Relation of Amy Mcbride Wendell

Insider Network Chart

Amy Mcbride Wendell Owned Company Details

What does Axogen Inc do?

Who are the key executives at Axogen Inc?

Amy Mcbride Wendell is the director of Axogen Inc. Other key executives at Axogen Inc include Chief R&D Officer Angelo Scopelianos , director & CEO Karen L. Zaderej , and VP & Clinical&Translational Sc Erick Wayne Devinney .

Axogen Inc (AXGN) Insider Trades Summary

Over the past 18 months, Amy Mcbride Wendell made 1 insider transaction in Axogen Inc (AXGN) with a net purchase of 10,000. Other recent insider transactions involving Axogen Inc (AXGN) include a net sale of 74,448 shares made by Gregory Gene Freitag , a net sale of 42,343 shares made by Michael Patrick Donovan , and a net sale of 39,280 shares made by Karen L. Zaderej .

In summary, during the past 3 months, insiders sold 0 shares of Axogen Inc (AXGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 180,030 shares of Axogen Inc (AXGN) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 150,030 shares.

Axogen Inc (AXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Axogen Inc Insider Transactions

No Available Data

Amy Mcbride Wendell Mailing Address

Above is the net worth, insider trading, and ownership report for Amy Mcbride Wendell. You might contact Amy Mcbride Wendell via mailing address: Covidien Ltd., 15 Hampshire Street, Mansfield Ma 02048.